Josh Brown and Sean Russo from Ritholtz Wealth Management discuss the current market trend favoring healthcare stocks, particularly in light of a recent downturn in technology shares following a higher-than-expected Consumer Price Index (CPI) report.
Adam Parker from Trivariate Research has been advocating for healthcare for 21 months, noting its appeal due to fast growth and upward earnings revisions, despite some clients perceiving the sector as crowded. Waters Corporation (WAT) and Thermo Fisher Scientific (TMO) are singled out for their strong performance and growth potential.
WAT, which specializes in laboratory instruments, has seen its stock rise significantly after a merger that doubled its revenue base. It reported Q2 earnings exceeding expectations and raised its full-year growth guidance.
TMO, the largest player in life science tools, has also performed well, with its stock reaching record highs and analysts raising price targets following strong earnings and positive management outlook. Both companies are positioned to benefit from the healthcare sector's momentum, which is currently outperforming the broader market.
Investors are advised to monitor key price levels for both stocks to manage risk effectively